Anthony D’Urzo

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Anthony D’Urzo, Gary T. Ferguson, J.A. van Noord et al. · Respiratory Research · 2011 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study

D. A. Mahler, Marc Decramer, Anthony D’Urzo et al. · European Respiratory Journal · 2013 · 162 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

Donald A. Mahler, Anthony D’Urzo, Eric Bateman et al. · Thorax · 2012 · 154 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +16

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Anthony D’Urzo, Stephen I. Rennard, Edward Kerwin et al. · Respiratory Research · 2014 · 147 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

Edward Kerwin, Anthony D’Urzo, Arthur F. Gelb et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 133 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16